Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for inhibiting tumor growth or treating cancer by administering an immunoglobulin single variable domain that binds glucocorticoid-induced TNFR family-related receptor (GITR)

Methods for inhibiting tumor growth or treating cancer by administering an immunoglobulin single variable domain that binds glucocorticoid-induced TNFR family-related receptor (GITR)

US Patent 11919966 · Granted Mar 5, 2024

Estimated economic value: $17,814,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of screening for anti-drug antibodies against immunoglobulin single varia2025
Dynamically reducing latency in processing pipelines2025
Techniques for predicting, detecting and reducing aspecific protein interference2024
Polypeptides comprising immunoglobulin single variable domains targeting glypica2024
Techniques for predicting, detecting and reducing aspecific protein interference2023
Chemokine receptor binding polypeptides2022
Techniques for predicting, detecting and reducing aspecific protein interference2021
Serum albumin binding proteins containing immunoglobulin single variable domains2021
Polypeptides that bind glucocorticoid-induced TNFR family-related receptor (GITR2021
Polypeptides that bind glucocorticoid-induced TNFR family-related receptor (GITR2021
Polypeptides that bind glucocorticoid-induced TNFR family-related receptor (GITR2021
Polypeptides that bind glucocorticoid-induced TNFR family-related receptor (GITR2021